Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001013594-26-000251·FENNEC PHARMACEUTICALS INC.
Schedule 13G ownership disclosure
Fennec Pharmaceuticals Inc
Common stock, no par value (the "Shares") · CUSIP: 31447P100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sonic Fund II, L.P.
Shares: 2,607,357 · Class: 7.6%
- Sonic GP LLC
Shares: 2,607,357 · Class: 7.6%
- Kam Lawrence
Shares: 2,799,959 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-26-000251
- Form type
- SCHEDULE 13G/A
- Filer
- FENNEC PHARMACEUTICALS INC.
- CIK
- CIK 1211583
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership